Milestone Pharmaceuticals Inc. — Director's Dealing 2019

Sep 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2019-09-09

Reporting Person: Hasija Amit (CFO & EVP of Corp. Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-09	Employee Stock Option (right to buy)	$22.45	A	147000	Acquired	2029-09-09	Common Shares (147000)	Direct

Footnotes

F1: One-fourth (1/4th) of the shares subject to the option vest on September 9, 2020 and one forty-eighth (1/48th) of the shares subject to the option vest on each one month anniversary thereafter, subject to the Reporting Person continuing to provide service through each such date.